NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Skye Bioscience, Inc.

Skye Bioscience, Inc.

Public
SAN DIEGON/Ahttps://skyebioscience.com/

Last Round

Private Placement

Feb 12, 2024

Total Funding Raised

$49.99M

Company Overview

Skye Bioscience, Inc. is a clinical-stage biotechnology company that focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases.

AI Layer

Non-AI

Keywords

obesity treatmentweight loss drugCB1 inhibitorperipheral CB1 inhibitorGLP-1 alternativemetabolic disease treatmentanti-obesity drugclinical-stage biopharmaG-protein-coupled receptorsGPCRsmuscle sparing weight lossmonoclonal antibodyglaucoma treatmentMASH treatmentnegative allosteric modulatorfirst-in-class therapeutic

Skye Bioscience, Inc. Comps

Public and private peers based on sector, stage, and business model.

Skye Bioscience, Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Skye Bioscience, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementFeb 12, 2024
View all Funding Rounds

Skye Bioscience, Inc. Investors

Notable investors and investment history

Skye Bioscience, Inc. investors
InvestorRounds
Ally Bridge GroupPrivate Placement
Altium CapitalPrivate Placement
5AM VenturesPrivate Placement
Driehaus Capital ManagementPrivate Placement
Sphera Funds ManagementPrivate Placement
View all Investors

Skye Bioscience, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Skye Bioscience, Inc. Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersSAN DIEGO
Employee Range18
Year Founded2011
Last FundingFeb 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.